These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11910440)

  • 1. [Brazilian policy for the distribution and production of antiretroviral drugs: a privilege or a right?].
    Galvao J
    Cad Saude Publica; 2002; 18(1):213-9. PubMed ID: 11910440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do patents for antiretroviral drugs constrain access to AIDS treatment in Africa?
    Attaran A; Gillespie-White L
    JAMA; 2001 Oct; 286(15):1886-92. PubMed ID: 11597292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rights, patents, markets and the global AIDS pandemic.
    Gathii JT
    Fla J Int Law; 2002; 14(2):261-352. PubMed ID: 16526139
    [No Abstract]   [Full Text] [Related]  

  • 4. In the high court of South Africa, case no. 4138/98: the global politics of access to low-cost AIDS drugs in poor countries.
    Barnard D
    Kennedy Inst Ethics J; 2002 Jun; 12(2):159-74. PubMed ID: 12476916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canada to change patent law to allow export of cheap drugs.
    Kondro W
    Lancet; 2003 Oct; 362(9392):1290. PubMed ID: 14577437
    [No Abstract]   [Full Text] [Related]  

  • 6. TRIPS AGREEMENT ARTICLE 31(B): THE NEED FOR REVISION.
    Effingham AM
    Seton Hall Law Rev; 2016; 46(3):883-909. PubMed ID: 27066613
    [No Abstract]   [Full Text] [Related]  

  • 7. India: New patent law may restrict access to HIV/AIDS treatments.
    Cruess G
    HIV AIDS Policy Law Rev; 2005 Aug; 10(2):28-30. PubMed ID: 16365971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral manufacturers and the challenge of universal access to drugs through the Brazilian National STD/AIDS Program.
    do Lago RF; Costa Ndo R
    Cad Saude Publica; 2009 Oct; 25(10):2273-84. PubMed ID: 19851626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pills, patents, and power: state creation of gray markets as a limit on patent rights.
    Ghosh S
    Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of civil society in protecting public health over commercial interests: lessons from Thailand.
    Ford N; Wilson D; Bunjumnong O; von Schoen Angerer T
    Lancet; 2004 Feb; 363(9408):560-3. PubMed ID: 14975620
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmaceutical patents and public health: challenges for the Brazilian antiretroviral treatment policy].
    Meiners CM
    Cad Saude Publica; 2008 Jul; 24(7):1467-78. PubMed ID: 18670671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Access to treatment for HIV/AIDS: a human rights issue in the developing world.
    Joni J
    Conn J Int Law; 2002; 17(2):273-80. PubMed ID: 12688296
    [No Abstract]   [Full Text] [Related]  

  • 13. The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS.
    Curti AM
    Am J Law Med; 2001; 27(4):469-85. PubMed ID: 11837145
    [No Abstract]   [Full Text] [Related]  

  • 14. Driving a decade of change: HIV/AIDS, patents and access to medicines for all.
    Hoen E'; Berger J; Calmy A; Moon S
    J Int AIDS Soc; 2011 Mar; 14():15. PubMed ID: 21439089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug resistance, patent resistance: Indian pharmaceuticals and the impact of a new patent regime.
    Halliburton M
    Glob Public Health; 2009; 4(6):515-27. PubMed ID: 19548158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The patent legislation in India fails the HIV/AIDS work].
    Holen Ø
    Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2666-7. PubMed ID: 16215618
    [No Abstract]   [Full Text] [Related]  

  • 17. Access to antiretroviral treatment in Latin American countries and the Caribbean.
    Chequer P; Cuchí P; Mazin R; García Calleja JM
    AIDS; 2002 Dec; 16 Suppl 3():S50-7. PubMed ID: 12685925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global patent police block cost-reduction efforts.
    Kasper T
    GMHC Treat Issues; 1999 Mar; 13(3):1-2. PubMed ID: 11366201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Access to antiretroviral drugs in Brazil.
    Galvão J
    Lancet; 2002 Dec; 360(9348):1862-5. PubMed ID: 12480377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New 20 year patents threaten to end AIDS drugs for developing countries.
    Dyer O
    BMJ; 2004 Dec; 329(7478):1308. PubMed ID: 15576738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.